Spotlight on Moderna: Analyzing the Surge in Options Activity

Jan 7, 2025 · Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 16 unusual trades.Delving into the …

$15
OFF

Spotlight On Robinhood Markets: Analyzing The Surge In Options …

2 weeks from now

1 day ago · Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $60.0 for Robinhood Markets over the recent three …

nasdaq.com

$10
OFF

Spotlight On IonQ: Analyzing The Surge In Options Activity

2 weeks from now

Jan 7, 2025 · Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $75.0 for IonQ over the recent three months. Insights …

nasdaq.com

$300
OFF

Spotlight On Tesla: Analyzing The Surge In Options Activity

2 weeks from now

Jan 6, 2025 · Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tesla's whale activity within a strike price range from $300.0 to …

nasdaq.com

46%
OFF

Spotlight On FTAI Aviation: Analyzing The Surge In Options Activity

2 weeks from now

2 days ago · This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 46% leaning bullish and 38% bearish. Among these …

sahmcapital.com

$155
OFF

Spotlight On Procter & Gamble: Analyzing The Surge In Options …

2 weeks from now

5 days ago · Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $155.0 to $170.0 for Procter & Gamble over the recent three …

nasdaq.com

37%
OFF

Spotlight On IREN: Analyzing The Surge In Options Activity

2 weeks from now

1 day ago · The general mood among these heavyweight investors is divided, with 37% leaning bullish and 62% bearish. Among these notable options, 3 are puts, totaling $216,548, and 5 …

nasdaq.com

$45
OFF

Spotlight On Las Vegas Sands: Analyzing The Surge In Options …

2 weeks from now

1 day ago · Predicted Price Range Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $45.0 to $52.5 for Las …

nasdaq.com

50%
OFF

Spotlight On Eli Lilly And Co: Analyzing The Surge In Options …

2 weeks from now

Jun 17, 2024 · The general mood among these heavyweight investors is divided, with 50% leaning bullish and 10% bearish. Among these notable options, 2 are puts, totaling $99,275, …

nasdaq.com

FAQs about Spotlight on Moderna: Analyzing the Surge in Options Activity Coupon?

When will Moderna announce its fourth-quarter results?

Moderna made its announcement Monday ahead of a presentation at the annual J.P. Morgan Healthcare Conference in San Fransisco. The company will detail its fourth-quarter results on Feb. 14. Moderna is a couple years removed from pulling in more than $19 billion in sales annually after initial vaccination rounds during the pandemic. ...

Did Moderna generate minimal sales in the year?

The company said that generated minimal sales in the year. Moderna made its announcement Monday ahead of a presentation at the annual J.P. Morgan Healthcare Conference in San Fransisco. The company will detail its fourth-quarter results on Feb. 14. ...

What happened to Moderna?

Moderna is a couple years removed from pulling in more than $19 billion in sales annually after initial vaccination rounds during the pandemic. Shares of Cambridge, Massachusetts-based Moderna Inc. fell 19%, or $8.18, to $34.07 in morning trading. ...

Will Moderna cut costs in 2026?

The company also said it was speeding up and expanding a cost-cutting plan. It expects to cut cash costs by $1 billion in the new year, with additional cuts planned in 2026. Moderna pulled in most of its revenue last year from its COVID-19 vaccine, Spikevax, which brought in more than $3 billion in sales. ...

Why did Moderna's shares tumble in early trading Monday?

(AP Photo/Eugene Hoshiko, File) Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to range between $1.5 billion and $2.5 billion after hitting as much as $3.1 billion last year. ...